<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11733">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02084706</url>
  </required_header>
  <id_info>
    <org_study_id>2013P002370</org_study_id>
    <nct_id>NCT02084706</nct_id>
  </id_info>
  <brief_title>Needle-Free Injection of Lidocaine for Local Anesthesia Prior to Trigger Digit Injection</brief_title>
  <acronym>J-tip</acronym>
  <official_title>Needle-Free Injection of Lidocaine for Local Anesthesia Prior to Trigger Digit Injection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Jet-injection (J-tip) is a rapid, minimally invasive delivery system that can be used for
      the subdermal injection of lidocaine solution for anesthetic purposes. The device has been
      found effective in pain reduction during IV catheterization in adults and children and
      lumbar puncture in children when compared to placebo saline-jet injection. [1-4].

      We believe that administering local anesthetic via J-tip prior to triamcinolone(40 mg/ml)
      injection could mitigate pain that occurs during and immediately following injection while
      preserving the post-injection pain relief of anesthetic injection. Furthermore,
      pre-placement of the jet-injected local anesthetic may obviate the need for the inclusion of
      local anesthetic into the triamcinolone injection. This would decrease the amount of fluid
      injected, which could have positive pain modulation by decreased tissue disruption.

      Objective: To evaluate the effectiveness of needle free jet injection (J-tip) administration
      of 2% lidocaine in reduction of the pain experienced during trigger digit 40 mg/ml
      triamcinolone injection.

      Hypothesis: Needle free jet injection (J-tip) administration of 2% lidocaine will prove an
      equal or superior means of pain reduction when compared to 2% lidocaine injection in the
      setting of trigger digit triamcinolone injections.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)</study_design>
  <primary_outcome>
    <measure>Visual-analog score (VAS)</measure>
    <time_frame>Our outcome measure will be collected within the 60 seconds following the steroid injection.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Group one subjects will then receive an injection of 0.5mL of 40 mg/ml triamcinolone and 0.5 mL of 2% Lidocaine over the A1 pulley; group two subjects will receive a J-tip administration of 0.5mL of 2% lidocaine prior (2-10 minutes) to needle injection of 0.5mL of 40 mg/ml triamcinolone. Members of both groups will then complete the Visual Analog Scale pain assessment; this recorded score is the primary study endpoint.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Trigger Finger</condition>
  <arm_group>
    <arm_group_label>Triamcinolone (20 g) and 2% Lidocaine injection over A1 pulley</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group one subjects will receive an injection of 0.5mL (20 g) of Triamcinolone and 0.5 mL of 2% Lidocaine over the A1 pulley.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>J-tip lidocaine administration, then steroid injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group two subjects will receive a needle free &quot;J-tip&quot; administration of 0.5mL of 2% lidocaine prior (2-10 minutes) to needle injection of 0.5mL of Triamcinolone (20 g) over the A1 pulley.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Triamcinolone (20 g) and 2% Lidocaine injection over the A1 pulley</intervention_name>
    <arm_group_label>Triamcinolone (20 g) and 2% Lidocaine injection over A1 pulley</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2% Lidocaine</intervention_name>
    <arm_group_label>Triamcinolone (20 g) and 2% Lidocaine injection over A1 pulley</arm_group_label>
    <arm_group_label>J-tip lidocaine administration, then steroid injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triamcinolone (20 g)</intervention_name>
    <arm_group_label>Triamcinolone (20 g) and 2% Lidocaine injection over A1 pulley</arm_group_label>
    <arm_group_label>J-tip lidocaine administration, then steroid injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>J-tip lidocaine administration</intervention_name>
    <arm_group_label>J-tip lidocaine administration, then steroid injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Triamcinolone (20 g) Injection over the A1 pulley.</intervention_name>
    <arm_group_label>J-tip lidocaine administration, then steroid injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who present to the Hand Clinic at Brigham and Women's Hospital or Brigham
             and Women's Faulkner Hospital, are 18 years of age or older and are indicated for a
             trigger digit steroid injection will be eligible for participation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip E Blazar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philip E Blazar, M.D.</last_name>
    <phone>617-732-5384</phone>
    <email>pblazar@partners.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philip E Blazar, MD</last_name>
      <phone>617-732-5384</phone>
      <email>pblazar@partners.org</email>
    </contact>
    <investigator>
      <last_name>Philip E Blazar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brandon E Earp, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Lysakowski C, Dumont L, Tram√®r MR, Tassonyi E. A needle-free jet-injection system with lidocaine for peripheral intravenous cannula insertion: a randomized controlled trial with cost-effectiveness analysis. Anesth Analg. 2003 Jan;96(1):215-9, table of contents.</citation>
    <PMID>12505955</PMID>
  </reference>
  <reference>
    <citation>Jimenez N, Bradford H, Seidel KD, Sousa M, Lynn AM. A comparison of a needle-free injection system for local anesthesia versus EMLA for intravenous catheter insertion in the pediatric patient. Anesth Analg. 2006 Feb;102(2):411-4.</citation>
    <PMID>16428534</PMID>
  </reference>
  <reference>
    <citation>Spanos S, Booth R, Koenig H, Sikes K, Gracely E, Kim IK. Jet Injection of 1% buffered lidocaine versus topical ELA-Max for anesthesia before peripheral intravenous catheterization in children: a randomized controlled trial. Pediatr Emerg Care. 2008 Aug;24(8):511-5.</citation>
    <PMID>18645542</PMID>
  </reference>
  <reference>
    <citation>Kolind-Sorensen V. Treatment of trigger fingers. Acta Orthop Scand. 1970;41(4):428-32.</citation>
    <PMID>5537268</PMID>
  </reference>
  <reference>
    <citation>Lapidus PW, Guidotti FP. Stenosing tenovaginitis of the wrist and fingers. Clin Orthop Relat Res. 1972 Mar-Apr;83:87-90.</citation>
    <PMID>5014835</PMID>
  </reference>
  <reference>
    <citation>Rhoades CE, Gelberman RH, Manjarris JF. Stenosing tenosynovitis of the fingers and thumb. Results of a prospective trial of steroid injection and splinting. Clin Orthop Relat Res. 1984 Nov;(190):236-8.</citation>
    <PMID>6488636</PMID>
  </reference>
  <reference>
    <citation>Murphy D, Failla MJ, Koniuch MP: steoid versus placebe injection for trigger finger, J Hand Surg [Am] 1995;20:628-631</citation>
  </reference>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 10, 2014</lastchanged_date>
  <firstreceived_date>March 5, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Philip Blazar, MD</investigator_full_name>
    <investigator_title>Associate Professor, Harvard Medical School</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Trigger Finger Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
